<bill session="115" type="h" number="5865" updated="2023-01-11T13:39:29Z">
  <state datetime="2018-05-17">REFERRED</state>
  <status>
    <introduced datetime="2018-05-17"/>
  </status>
  <introduced datetime="2018-05-17"/>
  <titles>
    <title type="display">Addiction Prevention and Responsible Opioid Practices Act</title>
    <title type="official" as="introduced">To establish programs related to prevention of prescription opioid misuse, and for other purposes.</title>
    <title type="short" as="introduced">Addiction Prevention and Responsible Opioid Practices Act</title>
  </titles>
  <sponsor bioguide_id="C001090"/>
  <cosponsors/>
  <actions>
    <action datetime="2018-05-17">
      <text>Introduced in House</text>
    </action>
    <action datetime="2018-05-17" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Ways and Means, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-05-17">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Ways and Means, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-05-17">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Ways and Means, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-05-17">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Ways and Means, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-06-04">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2018-07-24">
      <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSJU" name="House Judiciary" subcommittee="" activity="Referral"/>
    <committee code="HSJU08" name="House Judiciary" subcommittee="Crime and Federal Government Surveillance" activity="Referral"/>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
    <committee code="HSED" name="House Education and the Workforce" subcommittee="" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="115" type="s" number="2729" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Alternative treatments"/>
    <term name="Business ethics"/>
    <term name="Business records"/>
    <term name="Congressional oversight"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug therapy"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Government information and archives"/>
    <term name="Government studies and investigations"/>
    <term name="Health care quality"/>
    <term name="Health information and medical records"/>
    <term name="Health personnel"/>
    <term name="Health programs administration and funding"/>
    <term name="Health promotion and preventive care"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Hospital care"/>
    <term name="Indian social and development programs"/>
    <term name="Licensing and registrations"/>
    <term name="Marketing and advertising"/>
    <term name="Medical education"/>
    <term name="Medical ethics"/>
    <term name="Medicare"/>
    <term name="Military medicine"/>
    <term name="Minority health"/>
    <term name="Prescription drugs"/>
    <term name="Sales and excise taxes"/>
    <term name="State and local government operations"/>
    <term name="User charges and fees"/>
    <term name="Veterans' medical care"/>
  </subjects>
  <amendments/>
  <summary date="2019-08-06T22:19:59Z" status="Introduced in House">Addiction Prevention and Responsible Opioid Practices Act

This bill establishes a series of requirements relating to opioid regulation, prescribing, and monitoring, including licensure requirements for pharmaceutical representatives, a national opioid drug mapping tool to monitor prescribing practices of Medicaid providers, and an excise tax on opioid manufacturers.</summary>
</bill>
